Project Grant HT94252410105
- This federal Project Grant award of $437,967.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Diego (UCSD) focused on arterial disease in vascular Ehlers-Danlos syndrome and the potential role of oxidative stress. The award, effective January 1, 2025 through December 31, 2026, will fund comprehensive research services and scientific investigations at UCSD, a renowned...
- The University of California, San Diego (UCSD) was awarded a $1,197,884.00 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, awarded on Aug 15, 2025, supports research to investigate the mechanism and develop models of the human PD1 protein in the context of melanoma. As a leading academic institution, UCSD will leverage its expertise in medical research and education to conduct this advanced biomedical...
- The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
- The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
- This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
- The University of California, San Diego (UCSD) was awarded a $592,500.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy." The award, which spans from February 1, 2025 to January 31, 2028, aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UCSD, a...
- The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
- The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
- The University of California, San Diego (UCSD) was awarded a $1,995,027.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "THERAPY FOR C9ALS USING ENGINEERED RNA-TARGETING ZINC FINGER PROTEINS". The award period runs from June 1, 2025 to May 31, 2028. The project aims to advance biomedical research that can transform healthcare for military service members, veterans, and the general public....
- The University of California, San Diego (UCSD), doing business as UC San Diego Health, was awarded a $1,580,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2025, will support a research project titled "Multiomic Approaches for Noninvasive Prediction of Inflammatory Bowel Disease Exacerbations." The project aims to develop innovative biomedical solutions to address critical health...
The University of California, San Diego (UCSD) has been awarded a $316,000.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). This two-year award, effective from February 1, 2024 to January 31, 2026, will support research to investigate "POSTVIRAL DYNAMICS AND DYSFUNCTION OF THE AUTONOMIC NERVOUS SYSTEM VIA ADHERENCE-INDEPENDENT LONGITUDINAL CARDIOPULMONARY MONITORING." The Military Medical Research and Development program funds a range of biomedical research to improve the health and care of military service members, veterans, and their families, with a focus on innovative, high-impact projects. This award to UCSD leverages the university's expertise in areas like cognitive science, neuroscience, and biomedical research to advance knowledge and develop solutions related to military medical priorities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $316.0k | 1/19/24 |